Cas:878807-40-0 8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride manufacturer & supplier

We serve Chemical Name:8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride CAS:878807-40-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride

Chemical Name:8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride
CAS.NO:878807-40-0
Synonyms:8-Nitro-chroman-3-ylamine hydrochloride
Molecular Formula:C9H11ClN2O3
Molecular Weight:230.64800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:81.07000
Exact Mass:230.04600
LogP:2.88250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 8-Nitro-chroman-3-ylamine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-Nitro-chroman-3-ylamine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Nitro-chroman-3-ylamine hydrochloride Use and application,8-Nitro-chroman-3-ylamine hydrochloride technical grade,usp/ep/jp grade.


Related News: In these situations, the API is not a single substance but the culmination of various ingredients. 8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride manufacturer Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride supplier The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. 8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 8-nitro-3,4-dihydro-2H-chromen-3-amine,hydrochloride factory More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries.